'מערכת אימד'-
- Abstract
Background: Brexpiprazole is a serotonin-dopamine activity modulator. We evaluated the effects of adjunctive treatment with brexpiprazole on sleep disturbances in patients with DSM-IV-TR major depressive disorder (MDD) and inadequate response to antidepressant treatment.
Andrew D. Krystal et al., Prim Care Companion CNS Disord 2016;18(5):doi:10.4088/PCC.15m01914